BET inhibition in renal and cardiovascular disease: What is the clinical roadmap?

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
The high risk diabetes patient: What is the need for novel approaches to reduce cardiovascular and renal risk?
- Luis M Ruilope, MD
Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease
Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease
Managing CKD, Diabetes & CVD: Is epigenetics a new way forward?
Molecular mechanisms involved in the beneficial effect of BET inhibition in experimental renal disease